Common Stock, Shares, Outstanding of GlobeStar Therapeutics Corp from 30 Sep 2010 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
GlobeStar Therapeutics Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2010 to 30 Jun 2024.
  • GlobeStar Therapeutics Corp Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 1,241,105,695, a 42% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

GlobeStar Therapeutics Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 1,241,105,695 +368,836,352 +42% 30 Jun 2024 10-Q 11 Oct 2024 2024 Q3
Q1 2024 1,162,921,101 +382,493,918 +49% 31 Mar 2024 10-Q 28 Jun 2024 2024 Q2
Q4 2023 1,049,750,653 +279,390,037 +36% 31 Dec 2023 10-Q 12 Mar 2024 2024 Q1
Q3 2023 996,119,530 +273,792,861 +38% 30 Sep 2023 10-Q 11 Oct 2024 2024 Q3
Q2 2023 872,269,343 +187,902,038 +27% 30 Jun 2023 10-Q 17 Aug 2023 2023 Q3
Q1 2023 780,427,183 +174,635,690 +29% 31 Mar 2023 10-Q 31 May 2023 2023 Q2
Q4 2022 770,360,616 +169,985,790 +28% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q1
Q3 2022 722,326,669 +160,830,943 +29% 30 Sep 2022 10-K 19 Jan 2024 2023 FY
Q2 2022 684,367,305 +207,534,673 +44% 30 Jun 2022 10-Q/A 23 Aug 2022 2022 Q3
Q1 2022 605,791,493 +130,152,718 +27% 31 Mar 2022 10-Q 01 Jun 2022 2022 Q2
Q4 2021 600,374,826 +144,887,198 +32% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 561,495,726 +125,277,384 +29% 30 Sep 2021 10-K 09 Jan 2023 2022 FY
Q2 2021 476,832,632 +93,712,472 +24% 30 Jun 2021 10-Q 23 Aug 2021 2021 Q3
Q1 2021 475,638,775 +171,360,557 +56% 31 Mar 2021 10-Q 21 May 2021 2021 Q2
Q4 2020 455,487,628 +245,186,596 +117% 31 Dec 2020 10-Q 28 Jan 2021 2021 Q1
Q3 2020 436,218,342 +265,751,059 +156% 30 Sep 2020 10-K 05 Jan 2022 2021 FY
Q2 2020 383,120,160 +274,281,075 +252% 30 Jun 2020 10-Q 14 Jul 2020 2020 Q3
Q1 2020 304,278,218 +204,036,367 +204% 31 Mar 2020 10-Q 05 May 2020 2020 Q2
Q4 2019 210,301,032 +125,212,179 +147% 31 Dec 2019 10-Q 14 Feb 2020 2020 Q1
Q3 2019 170,467,283 +101,144,262 +146% 30 Sep 2019 10-K 03 Dec 2020 2020 FY
Q2 2019 108,839,085 +48,211,579 +80% 30 Jun 2019 10-Q 02 Aug 2019 2019 Q3
Q1 2019 100,241,851 +45,657,784 +84% 31 Mar 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 85,088,853 +33,004,786 +63% 31 Dec 2018 10-Q 19 Feb 2019 2019 Q1
Q3 2018 69,323,021 +23,738,954 +52% 30 Sep 2018 10-K 31 Dec 2019 2019 FY
Q2 2018 60,627,506 +19,543,439 +48% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q3
Q1 2018 54,584,067 +16,000,000 +41% 31 Mar 2018 10-Q 21 May 2018 2018 Q2
Q4 2017 52,084,067 +14,800,000 +40% 31 Dec 2017 10-Q 15 Feb 2018 2018 Q1
Q3 2017 45,584,067 +12,063,400 +36% 30 Sep 2017 10-K 03 Jan 2019 2018 FY
Q2 2017 41,084,067 +9,563,400 +30% 30 Jun 2017 10-Q/A 23 Aug 2017 2017 Q3
Q1 2017 38,584,067 +28,561,524 +285% 31 Mar 2017 10-Q 19 May 2017 2017 Q2
Q4 2016 37,284,067 +27,545,524 +283% 31 Dec 2016 10-Q 10 Apr 2017 2017 Q1
Q3 2016 33,520,667 +24,727,249 +281% 30 Sep 2016 10-K 16 Jan 2018 2017 FY
Q2 2016 31,520,667 +31,149,965 +8403% 30 Jun 2016 10-Q/A 16 Sep 2016 2016 Q3
Q1 2016 10,022,543 -23,697,594 -70% 31 Mar 2016 10-Q/A 16 Jun 2016 2016 Q2
Q4 2015 9,738,543 -18,281,594 -65% 31 Dec 2015 10-Q 22 Feb 2016 2016 Q1
Q3 2015 8,793,418 +8,537,216 +3332% 30 Sep 2015 10-Q/A 16 Jun 2016 2016 Q2
Q2 2015 370,702 -20,389,324 -98% 30 Jun 2015 10-Q/A 24 Sep 2015 2015 Q3
Q1 2015 33,720,137 +18,906,407 +128% 31 Mar 2015 10-Q/A 17 Sep 2015 2015 Q2
Q4 2014 28,020,137 +14,906,407 +114% 31 Dec 2014 10-Q 17 Feb 2015 2015 Q1
Q3 2014 256,202 -10,607,528 -98% 30 Sep 2014 10-K/A 22 Jan 2016 2015 FY
Q2 2014 20,760,026 +11,496,296 +124% 30 Jun 2014 10-Q/A 04 Sep 2014 2014 Q3
Q1 2014 14,813,730 +6,277,315 +74% 31 Mar 2014 10-Q 20 May 2014 2014 Q2
Q4 2013 13,113,730 +6,917,315 +112% 31 Dec 2013 10-Q/A 21 Feb 2014 2014 Q1
Q3 2013 10,863,730 +5,217,315 +92% 30 Sep 2013 10-Q/A 04 Sep 2014 2014 Q3
Q2 2013 9,263,730 -4,436,270 -32% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 8,536,415 -3,463,585 -29% 31 Mar 2013 10-Q/A 16 May 2013 2013 Q2
Q4 2012 6,196,415 -5,803,585 -48% 31 Dec 2012 10-Q/A 07 Mar 2013 2013 Q1
Q3 2012 5,646,415 +5,046,415 +841% 30 Sep 2012 10-K/A 23 Jan 2014 2013 FY
Q2 2012 13,700,000 +1,700,000 +14% 30 Jun 2012 10-Q/A 20 Sep 2012 2012 Q3
Q1 2012 12,000,000 31 Mar 2012 10-Q 21 May 2012 2012 Q2
Q4 2011 12,000,000 31 Dec 2011 10-Q 14 Feb 2012 2012 Q1
Q3 2011 600,000 -8,400,000 -93% 30 Sep 2011 10-K/A 07 Mar 2013 2012 FY
Q2 2011 12,000,000 30 Jun 2011 10-Q 11 Aug 2011 2011 Q3
Q3 2010 9,000,000 30 Sep 2010 10-K 29 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.